
Injectable, Structural Regenerative Implant for Cartilage Care
Protect • Repair • Regenerate
Cartilage injuries can turn simple movement into a challenge. Without timely treatment, damage may progress and increase the risk of arthritis or future joint replacement.
At Liquid Cartilage, our goal is joint preservation and regeneration—not replacement. With ChondroFiller®, we deliver advanced, evidence-led care on Harley Street.

Cartilage provides the smooth, low-friction surface that lets your joints move comfortably. It doesn’t readily self-repair, but with the right scaffold and biological cues, regeneration is possible.
Act early to preserve more of what you have.

ChondroFiller® is an acellular, biologic collagen scaffold delivered in liquid form. Once placed, it gels within minutes, filling the defect and providing a framework that invites your cells to rebuild cartilage.
Think of it like “epoxy” for cartilage—without the plastic.
One treatment. One step. A chance to keep your joint for the long term.


ChondroFiller® sits in a different class— structural regenerative implant.
| Treatment | Analogy | What it Does | Limitation |
|---|---|---|---|
| HA (Hyaluronic Acid) | WD-40 | Improves lubrication for short-term comfort | Temporary; does not regenerate tissue |
| Arthrosamid® | Silicone | Acts on the synovium to reduce pain signalling | Not regenerative; literature notes complication rates up to 30% |
| ChondroFiller® | Epoxy resin | Fills defects, stabilises, and promotes true cartilage repair | Most robust injectable option for structural repair |
ChondroFiller®: our structural, regenerative approach to focal cartilage defects.
Small joints: thumb, fingers, elbow, AC joint, toes, TMJ…
From £2,100
Large joints: knee, hip, shoulder, ankle
From £2,800
Best for knee, hip, shoulder
From £6,500 (knee), £9,500 (hip/shoulder)
Our proprietary MSC Co-Delivery Technique
Introductory offer: your consultation fee is credited toward treatment if you proceed.

Quick, no-obligation chat

Comprehensive assessment with Prof. Paul Lee

Injection, Keyhole, or Liquid Cartilage™

Precise and minimally invasive



Cartilage damage won’t reverse on its own—yet with the right plan it can be protected, repaired, and regenerated.
At Liquid Cartilage, you access world-leading science and a joint-preservation vision on Harley Street.
(Consultation fee credited towards treatment if you proceed.)
Everything you want to know about ChondroFiller® at Liquid Cartilage.
ChondroFiller® is an acellular collagen gel that fills cartilage defects and forms a scaffold for your own cells to regenerate healthy tissue. Unlike temporary injections, it supports hyaline-like restoration for smoother motion and protection long-term.
HA or Arthrosamid® may give short-term pain relief, while ChondroFiller® aims to rebuild cartilage. Compared with replacement, it preserves your natural joint and avoids prosthesis risks. Our approach is regenerate-first.
Studies show +30 IKDC in knees, +33 Harris Hip Score in hips, and improved ankle metrics. MRI (MOCART) typically reads 70–87. Globally, >19,000 cases support safety and function.
Best for focal defects up to 6 cm² in knees, hips, ankles, or small joints. Active younger patients often benefit, but older patients may qualify if surrounding cartilage is stable.
Delivered via precise injection or keyhole surgery. The gel sets in minutes. Expect partial weight-bearing ~6 weeks, steady return to cycling/swimming, and most sports around ~12 months alongside specialist rehab.
Harley Street location; UK ICRS Centre of Excellence. Led by Prof. Paul Lee, with advanced options like Liquid Cartilage™ (ChondroFiller® + cells) to prioritise preservation.
Discover what makes ChondroFiller® unique at Liquid Cartilage.

Between 75 and 80 per cent of ankle osteoarthritis traces to old fractures; molecular degradation begins within two weeks of injury, yet symptoms commonly emerge only years later.

A collagen scaffold injection called ChondroFiller recruits the body's own repair cells into cartilage defects at the thumb base; a 2025 prospective study of 43 patients found significant pain reduction and functional improvement at six months.

An injected collagen scaffold recruits a patient's own mesenchymal stem cells to repair cartilage damage in the thumb and small hand joints, offering a minimally invasive alternative to pain management or joint reconstruction.

Throwing loads the elbow with compression and outward bending, damaging the humeral capitellum cartilage when repeated across hundreds of pitches weekly. This osteochondritis dissecans is a site-specific injury driven by cumulative load in developing athletes, distinct from degenerative osteoarthritis.

ChondroFiller is a liquid collagen scaffold that recruits the patient's own progenitor cells into focal cartilage defects. It works only for Grade III–IV lesions no larger than 6 cm² with stable borders, and placement demands real-time ultrasound guidance: landmark-only injection misses the target in 28–30% of cases.

Articular cartilage cannot self-repair; patients can receive ChondroFiller injections indefinitely through the Lifetime Preservation Programme, which schedules biennial top-ups adjusted by annual MRI monitoring.